China Literature Ltd
HKEX:772
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22.7
43.98
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
China Literature Ltd
stock under the Base Case scenario is
28.38
HKD.
Compared to the current market price of 36.46 HKD,
China Literature Ltd
is
Overvalued by 22%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for China Literature Ltd.
| US |
|
News Corp
NASDAQ:NWSA
|
|
| US |
|
New York Times Co
NYSE:NYT
|
|
| UK |
|
Pearson PLC
LSE:PSON
|
|
| NO |
|
Schibsted ASA
OSE:SCHA
|
|
| ZA |
C
|
Caxton and CTP Publishers and Printers Ltd
JSE:CAT
|
|
| DE |
|
Springer Nature AG & Co KgaA
XETRA:SPG
|
|
| CN |
|
Jiangsu Phoenix Publishing & Media Corp Ltd
SSE:601928
|
|
| SA |
|
Saudi Research and Media Group
SAU:4210
|
|
| FR |
|
Lagardere SA
PAR:MMB
|
|
| CN |
|
People.cn Co Ltd
SSE:603000
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
China Literature Ltd
Balance Sheet Decomposition
China Literature Ltd
| Current Assets | 11B |
| Cash & Short-Term Investments | 7B |
| Receivables | 1.9B |
| Other Current Assets | 2B |
| Non-Current Assets | 12.2B |
| Long-Term Investments | 5.2B |
| PP&E | 277.8m |
| Intangibles | 6.1B |
| Other Non-Current Assets | 670.2m |
| Current Liabilities | 3.7B |
| Accounts Payable | 1.1B |
| Accrued Liabilities | 493.9m |
| Other Current Liabilities | 2.2B |
| Non-Current Liabilities | 298.6m |
| Long-Term Debt | 135.7m |
| Other Non-Current Liabilities | 162.9m |
Free Cash Flow Analysis
China Literature Ltd
| CNY | |
| Free Cash Flow | CNY |
Earnings Waterfall
China Literature Ltd
|
Revenue
|
7.1B
CNY
|
|
Cost of Revenue
|
-3.7B
CNY
|
|
Gross Profit
|
3.5B
CNY
|
|
Operating Expenses
|
-4.1B
CNY
|
|
Operating Income
|
-607.5m
CNY
|
|
Other Expenses
|
743.7m
CNY
|
|
Net Income
|
136.2m
CNY
|
Profitability Score
Profitability Due Diligence
China Literature Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
China Literature Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Literature Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
China Literature Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China Literature Ltd
According to Wall Street analysts, the average 1-year price target for
China Literature Ltd
is 39.91 HKD
with a low forecast of 33.33 HKD and a high forecast of 52.5 HKD.
Dividends
Current shareholder yield for
China Literature Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
China Literature Ltd
stock under the Base Case scenario is
28.38
HKD.
Compared to the current market price of 36.46 HKD,
China Literature Ltd
is
Overvalued by 22%.